Judge: Investors Showed That Drug Maker Misrepresented Clinical Test Results
SANTA ANA, Calif. — Lead plaintiffs in a securities class action lawsuit against a pharmaceutical company and certain of its executive officers have shown that the defendants issued misrepresentations regarding the...To view the full article, register now.
Already a subscriber? Click here to view full article